PRESS RELEASE
FOR IMMEDIATE RELEASE

EQUIDONE¨ GEL (domperidone) RECEIVES
FDA VETERINARY APPROVAL

OVERLAND PARK, KS, SEPTEMBER 10, 2010 Ð Dechra Veterinary Products announces it has received FDA approval to market EQUIDONE¨ Gel, which contains the active ingredient domperidone.

EQUIDONE Gel is a patent protected new animal drug approval (NADA) and the only FDA approved product to prevent fescue toxicosis in periparturient mares. Each 25 cc EQUIDONE Gel syringe contains 2.75 grams of domperidone, which will provide treatment for an 1100 lb mare for five days. EQUIDONE Gel is an oral gel to be administered daily 10-15 days prior to the expected foaling date and can be continued for up to five days post foaling